Nastech Pharmaceutical Company Inc. Q...

Nastech Pharmaceutical Company Inc. Q1 2008 Earnings Call Transcript

There are 1 comment on the The Biotech Stock Blog story from May 28, 2008, titled Nastech Pharmaceutical Company Inc. Q1 2008 Earnings Call Transcript. In it, The Biotech Stock Blog reports that:

Matthew Haines - Senior Director of IR and Corporate Communications Stephen Quay - Chairman and CEO Gordon Brandt - President Bruce York - CFO Analysts Alex Quint - Quint Miller & Company Yale Jen - Maxim Group ...

Join the discussion below, or Read more at The Biotech Stock Blog.

JIMMY T

Since: May 08

Location hidden

#1 Jun 1, 2008
Actors have scripts and stock companies have earnings call transcripts.
The company takes questions from analysts who have been following NSTK for years. The same analysts who gave ratings of outperform to high target prices, while the stock price has gone down
from $18 dollars per share to $1.19 today.
Shareholders are listening to one sided questions and answers. There is no fair balance when all parties involved in the transcript call have been friendly in their relationship for years.
The reality is that after 12 months of news releases, ratings by research firms, target call prices,star mine expert ratings releases, and even
assistance from a T.V. personalty expert, this stock has tanked big time. So is it their pipeline or
is it the most touted stock in history that has gone absolutely nowhere in 24 years?

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Nastech Pharmaceutical Company Discussions

Title Updated Last By Comments
News MDRNA Announces Phase 2 Trial of PYY(3-36) Does... (Aug '08) Oct '13 Marguerite 2
News Nastech to Present at BMO Capital Markets Focus... (Nov '07) Feb '12 khgkbkjj 2
Nascobal gel (Aug '11) Aug '11 Judith Hladik-Voss 1
News Nastech Pharma seeks to spin off subsidiary MDR... (Jul '08) Jul '08 JIMMY T 1
News Nastech plans to change its name (May '08) May '08 JIMMY T 1
Nastech buyout coming soon (May '08) May '08 news 1
News Nastech raises $7.9M in stock sale; shares dive... (May '08) May '08 JIMMY T 2
More from around the web